Stifel Nicolaus Boosts Astrana Health (NASDAQ:ASTH) Price Target to $60.00

Astrana Health (NASDAQ:ASTH) had its price target increased by Stifel Nicolaus from $48.00 to $60.00 in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other equities analysts have also weighed in on the stock. Baird R W upgraded shares of Astrana Health to a strong-buy rating in a report on Thursday, May 30th. Robert W. Baird began coverage on Astrana Health in a research note on Thursday, May 30th. They set an outperform rating and a $54.00 price target on the stock. Finally, Truist Financial raised Astrana Health from a hold rating to a buy rating and raised their price objective for the company from $44.00 to $50.00 in a research note on Thursday, July 11th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Astrana Health currently has a consensus rating of Buy and an average target price of $53.50.

Astrana Health Stock Down 6.4 %

Astrana Health stock traded down $3.17 during mid-day trading on Thursday, hitting $46.11. 6,103 shares of the stock were exchanged, compared to its average volume of 171,807. The firm’s fifty day moving average price is $43.66. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.56. Astrana Health has a 12 month low of $28.86 and a 12 month high of $54.27. The firm has a market capitalization of $2.58 billion, a PE ratio of 37.33, a price-to-earnings-growth ratio of 1.83 and a beta of 1.16.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The company had revenue of $404.36 million for the quarter, compared to analyst estimates of $413.84 million. During the same period last year, the business earned $0.42 EPS. The business’s quarterly revenue was up 19.9% compared to the same quarter last year. As a group, analysts forecast that Astrana Health will post 1.42 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.